Seres Therapeutics Inc (MCRB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 45,766 | 30,793 | 127,965 | 163,030 | 180,002 |
| Marketable Securities | N/A | N/A | N/A | 18,311 | 110,704 |
| Receivables | 517 | 2,068 | N/A | N/A | N/A |
| Other current assets | 0 | 0 | 39,396 | 0 | 0 |
| TOTAL | $49,376 | $38,674 | $175,410 | $194,764 | $303,628 |
| Non-Current Assets | |||||
| PPE Net | 7,635 | 11,534 | 17,614 | 22,985 | 17,938 |
| Investments And Advances | 0 | 0 | 1,401 | 1,401 | 1,896 |
| Other Non-Current Assets | 81,182 | 89,602 | 164,175 | 129,634 | 31,397 |
| TOTAL | $88,817 | $101,136 | $183,190 | $154,020 | $51,231 |
| Total Assets | $138,193 | $139,810 | $358,600 | $348,784 | $354,859 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,682 | 4,079 | 3,641 | 17,440 | 13,735 |
| Accrued Expenses | 7,250 | 28,469 | 22,509 | 59,840 | 45,094 |
| TOTAL | $19,322 | $41,222 | $98,659 | $85,596 | $82,258 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | 101,544 | 50,591 | 24,643 |
| Deferred Revenues | N/A | N/A | N/A | 4,259 | 16,819 |
| Other Non-Current Liabilities | 74,653 | 84,804 | 203,253 | 109,384 | 29,453 |
| TOTAL | $74,653 | $84,804 | $304,797 | $252,405 | $141,094 |
| Total Liabilities | $93,975 | $126,026 | $403,456 | $338,001 | $223,352 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 9,586 | 8,718 | 7,550 | 6,304 | 4,601 |
| Common Shares | 10 | 9 | 135 | 125 | 92 |
| Retained earnings | -972,403 | -978,099 | -978,235 | -864,511 | -614,354 |
| Other shareholders' equity | 0 | 0 | 0 | -12 | -60 |
| TOTAL | $44,218 | $13,784 | $-44,856 | $10,783 | $131,507 |
| Total Liabilities And Equity | $138,193 | $139,810 | $358,600 | $348,784 | $354,859 |